Core Insights - UnitedHealth Group Incorporated (UNH) has a market capitalization of $265.6 billion and operates organized health systems, providing employee benefit programs globally [1] Performance Overview - UNH shares have underperformed the broader market, declining 44.8% over the past year, while the S&P 500 Index has increased by nearly 11.8% [2] - In 2026, UNH's stock fell 11.2%, contrasting with a slight dip in the S&P 500 on a year-to-date basis [2] - Compared to the iShares U.S. Healthcare Providers ETF (IHF), which declined about 12.1% over the past year and 3.5% year-to-date, UNH's underperformance is evident [3] Financial Results - On January 27, UNH shares dropped 19.6% following the release of fiscal 2025 Q4 results, where revenue increased by 12.3% year-over-year to $113.22 billion, driven by growth in Optum and enrollment in UnitedHealthcare's government programs, but slightly below consensus expectations [5] - Adjusted EPS was approximately $2.11, meeting expectations, but underlying profitability weakened due to high medical utilization and care costs compressing insurance margins, particularly in Medicare Advantage [5] - The company incurred $1.6 billion in charges related to Optum portfolio realignment and business optimization, impacting reported earnings and segment margins [5] Analyst Expectations - For the current fiscal year ending in December, analysts project UNH's EPS to rise by 8.2% to $17.69 on a diluted basis [6] - UNH has a mixed earnings surprise history, beating consensus estimates in two of the last four quarters while missing forecasts in two others [6] - Among 26 analysts covering UNH stock, the consensus rating is a "Moderate Buy," with 16 "Strong Buy" ratings, two "Moderate Buys," seven "Holds," and one "Strong Sell" [6] - The analyst configuration has become more bullish, with 15 analysts now suggesting a "Strong Buy" [7]

Core Insights - MetLife Inc. reported mixed financial performance for the third quarter of 2025, with an earnings per share (EPS) of $2.34, exceeding the estimated $2.31, driven by gains from its investment portfolio [2][5] - The company's revenue was $17.36 billion, falling short of the estimated $18.64 billion, while net income was reported at $818 million [3][5] - Adjusted earnings per share rose by 21% to $2.37, indicating robust growth in core operations, supported by a 15% increase in adjusted earnings to $1.6 billion [2][3] Financial Metrics - MetLife's price-to-earnings (P/E) ratio is approximately 12.31, suggesting investors are willing to pay $12.31 for every dollar of earnings [4] - The price-to-sales ratio is about 0.72, indicating the stock is valued at less than one times its sales, while the enterprise value to sales ratio is around 0.69 [4] - The company's debt-to-equity ratio stands at approximately 0.72, reflecting a balanced approach to financing its assets [4][5]

UnitedHealth Group Incorporated (UNH), headquartered in Minnetonka, Minnesota, owns and manages organized health systems. With a market cap of $324.9 billion, the company provides employers with products and resources to plan and administer employee benefit programs serving customers worldwide. The health insurance giant is expected to announce its fiscal third-quarter earnings for 2025 before the market opens on Tuesday, Oct. 28. Ahead of the event, analysts expect UNH to report a profit of $2.87 per sha ...